# dCas9-KRAB Cell Lines

Canonical: https://abierto.us/opportunities/75n95024q00198

- Solicitation number: 75N95024Q00198
- Notice type: Combined synopsis and solicitation
- Status: Closed. Deadline was March 22, 2024 at 4:00 PM EDT
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Nida (75N950)
- NAICS: 541380 Testing Laboratories and Services
- Product or service code: B504 Chemical/Biological Studies and Analysis
- Place of performance: Mountain View, California
- County: Santa Clara County (FIPS 06085). https://abierto.us/counties/santa-clara-county-ca-06085
- First posted: March 15, 2024
- Last posted: March 15, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/23e523779c8c4f51905539ed5c636f70/view

## Description

The solicitation number is 75N95024Q00198 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.

THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advanced Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to the following for the acquisition of six (6) dCas9-KRAB cell lines: Cellecta, Inc. 320 Logue Avenue, Mountain View, CA 94043 This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1).

This requirement is for the following services: The National Institutes of Health has established an RNAi/CRIPSR Cas9 screening facility to provide intramural researchers with access to the equipment and expertise necessary to conduct genome-wide RNAi/ CRIPSR Cas9 screens in mammalian cells. The NCATS Functional Genomics Lab requires six (6) dCas9 cell lines that will be used to repress the target gene expression when applied in a CRISPRi screen. See attached Statement of Work.

## Publications

- March 15, 2024: Combined synopsis and solicitation, due March 22, 2024 at 4:00 PM EDT. Notice 23e523779c8c4f51905539ed5c636f70. https://sam.gov/workspace/contract/opp/23e523779c8c4f51905539ed5c636f70/view

## Points of contact

- Sarah Adan, sarah.adan@nih.gov, 3014805422

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n95024q00198.